Dr. Julia Ding, MD

Dr. Ding practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Ding's NPI, 1669901757, was assigned on June 12, 2017. Dr. Ding holds New Hampshire license 25721.

Dr. Ding's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Ding's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Ding to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ding practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Ding's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Ding's licenses on file in 2 states: New Hampshire and Rhode Island.

CMS data shows 29 Medicare services from Dr. Ding across 2 procedure codes in 2024, for 43 Medicare patients. Medicare paid $4,048 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 43 Medicare patients who saw Dr. Ding in 2024. The largest group is 65 to 74, with 24 patients. 67% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ding's median patient age at 67, with 60% women.

In 2024, Dr. Ding wrote 60 Medicare Part D claims for 18 patients. 65% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $6,498 in total drug cost. In 2022, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Ding for performance year 2024, reported through an alternative payment model (APM). Dr. Ding accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 68 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ding, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Ding, published from 2017 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Antibodies, Monoclonal, Electrophoresis, Capillary and Biological Products. Dr. Ding has published most often in Biotechnol Bioeng. Dr. Ding's most frequent co-authors are Hal Blumenfeld, MD, Thomas Dohlman, MD and Stephan Bickel, MD, PhD.

CMS Open Payments shows 37 general payments to Dr. Ding from 4 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $4,694.